Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (571-580 of 688) with videos related to

Pageof 69
Sort By:
Journal of the American College of Cardiology|January 2, 2025
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 TrialsHenri Lu, Toru Kondo, Brian L Claggett, et al.
Circulation. Heart Failure|October 22, 2021
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection FractionMasatoshi Minamisawa, Brian Claggett, Kota Suzuki, et al.
Circulation|August 12, 2024
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA TrialSanjay Rajagopalan, Mirela Dobre, Jean-Eudes Dazard, et al.
JAMA Cardiology|September 27, 2024
Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.
Nature Reviews. Cardiology|December 23, 2016
Expert consensus document: Mitochondrial function as a therapeutic target in heart failureDavid A Brown, Justin B Perry, Mitchell E Allen, et al.
Journal of Cardiac Failure|April 8, 2026
Performance of the HFpEF-ABA, H<sub>2</sub>FPEF, and HFA-PEFF Algorithms in HFpEF: A Participant-Level Pooled Analysis of Randomized Clinical TrialsJohn W Ostrominski, Fernando A Lara Lince, Brian L Claggett, et al.
European Journal of Heart Failure|April 13, 2025
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2025
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populationsHiddo J L Heerspink, Rajiv Agarwal, Antonio J Amor, et al.
European Journal of Heart Failure|September 29, 2023
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fractionShingo Matsumoto, Toru Kondo, Mingming Yang, et al.
Pageof 69

Showing results (571-580 of 688) with videos related to

Sort By:
Pageof 69
Journal of the American College of Cardiology|January 2, 2025
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 TrialsHenri Lu, Toru Kondo, Brian L Claggett, et al.
Circulation. Heart Failure|October 22, 2021
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection FractionMasatoshi Minamisawa, Brian Claggett, Kota Suzuki, et al.
Circulation|August 12, 2024
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA TrialSanjay Rajagopalan, Mirela Dobre, Jean-Eudes Dazard, et al.
JAMA Cardiology|September 27, 2024
Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.
Nature Reviews. Cardiology|December 23, 2016
Expert consensus document: Mitochondrial function as a therapeutic target in heart failureDavid A Brown, Justin B Perry, Mitchell E Allen, et al.
Journal of Cardiac Failure|April 8, 2026
Performance of the HFpEF-ABA, H<sub>2</sub>FPEF, and HFA-PEFF Algorithms in HFpEF: A Participant-Level Pooled Analysis of Randomized Clinical TrialsJohn W Ostrominski, Fernando A Lara Lince, Brian L Claggett, et al.
European Journal of Heart Failure|April 13, 2025
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2025
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populationsHiddo J L Heerspink, Rajiv Agarwal, Antonio J Amor, et al.
European Journal of Heart Failure|September 29, 2023
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fractionShingo Matsumoto, Toru Kondo, Mingming Yang, et al.
Pageof 69